Imperial College London
Action of hormone replacement therapy on insulin secretion merits further study
Published in Elder Law Weekly, January 11th, 2006
According to a report from England, "There is a persistent perception that estrogens have an adverse effect on carbohydrate metabolism. It might therefore be expected that their use would result in a corresponding increase in the incidence of diabetes."
"Recent evidence from clinical trials suggesting that women on postmenopausal estrogen hormone replacement therapy (HRT) have a reduced incidence of type 2 diabetes therefore appears paradoxical," wrote I.F. Godsland and colleagues....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Elder Law Weekly
Source: Elder Law Weekly (2006-01-11)
More Articles from Elder Law Weekly
- Applied NeuroSolutions, Inc.
Alzheimer disease therapy developer renews consulting agreement with Peter Davies - Center for Clinical and Basic Research, Ballerup
Drospirenone/estrogen combination is effective in preventing bone loss - Howard Hughes Medical Institute
Culprit in Alzheimer disease may have a good side
Insurance status among African-American women is strongest predictor for mammography use- Aastrom Biosciences, Inc.
Second clinical trial for bone fractures therapy initiated in Spain - Affymetrix, Inc.
Alliance formed to identify genes associated with cardiovascular disease, diabetes and cancer - More from this issue of Elder Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
